Global Smoking Cessation Aids Market

Smoking Cessation Aids Comprehensive Study by Type (Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays), Spray, Drug, Electronic Cigarettes, Others), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Distribution Channels (Supermarkets, Vape Shops, Online, Tobacconists) Players and Region - Global Market Outlook to 2027

Smoking Cessation Aids Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Smoking Cessation Aids Market Scope?
Smoking Cessation Aids refers to the process of stopping tobacco smoking. Tobacco used in cigarettes are causing serious health problems towards human, hence it is necessary to quit smoking. These smoking cessation aids help in reducing risk related to smoking diseases. As smoking increases the ratio of many disease and death it is important to stop smoking. It is seen that the global retail sales associated with the nicotine ecosystem during 2017 were approximately USD 785 billion in which cigarettes made up about 89.1 percent of the global retail nicotine ecosystem by sales value. Consumption of cigarettes globally is driving the market for smoking cessation aids.

The Smoking Cessation Aids market study is being classified by Type (Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays), Spray, Drug, Electronic Cigarettes and Others), by Application (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and major geographies with country level break-up.

Analysts at AMA predicts that Vendors from Global will contribute to the maximum growth of Global Smoking Cessation Aids market throughout the predicted period.

Reckitt Benckiser (United Kingdom), Pfizer (United States), GlaxoSmithKline (United Kingdom), Roche (Switzerland), Novartis (Switzerland), Johnson and Johnson (United States), Bayer (Germany), Cipla (India), Takeda Pharmaceuticals (Japan) and NJOY (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Smoking Cessation Aids market by Type, Application and Region.

On the basis of geography, the market of Smoking Cessation Aids has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
On February 2019, Antidote Therapeutics announced a collaboration with the National Cancer Institute to Develop ATI-1013, a novel nicotine-binding antibody, for reducing lung cancer in high-risk smokers

According to Ministry of Health websites, its regulate e-cigarettes were classified as new/amended laws or existing laws. The policy domains identified include restrictions or prohibitions on the product: sale, manufacturing, importation, distribution, use, product design including e-liquid ingredients, advertising/promotion/sponsorship, trademarks, and regulation requiring: taxation, health warning labels, and child-safety standards.

Influencing Market Trend
  • Adoption of E-Cigarettes as an Alternative towards Cigarettes Cessation Aids
  • Innovation in Smoking Cessation Products

Market Drivers
  • Increasing Number of People Consuming Cigarettes Globally
  • Stringent Government Rules and Regulation
  • High Awareness of Risk Associated with Smoking Cigarettes

Opportunities
  • Rising Awareness amongst Smokers on Hazards of Smoking
  • Banning Of Tobacco Product Advertisement in Many Countries

Restraints
  • High Prices of These Smoking Cessation Aids

Challenges
  • Side Effects Related To Drugs and Therapies


Key Target Audience
Smoking Cessation Aids Manufacturers, Smoking Cessation Aids Traders, End-Use Market Participants of Different Segments of Smoking Cessation Aids, Government and Research Organizations, R&D Institutions and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays)
  • Spray
  • Drug
  • Electronic Cigarettes
  • Others
By Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Distribution Channels
  • Supermarkets
  • Vape Shops
  • Online
  • Tobacconists

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of People Consuming Cigarettes Globally
      • 3.2.2. Stringent Government Rules and Regulation
      • 3.2.3. High Awareness of Risk Associated with Smoking Cigarettes
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Related To Drugs and Therapies
    • 3.4. Market Trends
      • 3.4.1. Adoption of E-Cigarettes as an Alternative towards Cigarettes Cessation Aids
      • 3.4.2. Innovation in Smoking Cessation Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Smoking Cessation Aids, by Type, Application, Distribution Channels and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Smoking Cessation Aids (Value)
      • 5.2.1. Global Smoking Cessation Aids by: Type (Value)
        • 5.2.1.1. Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays)
        • 5.2.1.2. Spray
        • 5.2.1.3. Drug
        • 5.2.1.4. Electronic Cigarettes
        • 5.2.1.5. Others
      • 5.2.2. Global Smoking Cessation Aids by: Application (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Online Pharmacies
      • 5.2.3. Global Smoking Cessation Aids by: Distribution Channels (Value)
        • 5.2.3.1. Supermarkets
        • 5.2.3.2. Vape Shops
        • 5.2.3.3. Online
        • 5.2.3.4. Tobacconists
      • 5.2.4. Global Smoking Cessation Aids Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Smoking Cessation Aids (Volume)
      • 5.3.1. Global Smoking Cessation Aids by: Type (Volume)
        • 5.3.1.1. Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays)
        • 5.3.1.2. Spray
        • 5.3.1.3. Drug
        • 5.3.1.4. Electronic Cigarettes
        • 5.3.1.5. Others
      • 5.3.2. Global Smoking Cessation Aids by: Application (Volume)
        • 5.3.2.1. Hospital Pharmacies
        • 5.3.2.2. Retail Pharmacies
        • 5.3.2.3. Online Pharmacies
      • 5.3.3. Global Smoking Cessation Aids by: Distribution Channels (Volume)
        • 5.3.3.1. Supermarkets
        • 5.3.3.2. Vape Shops
        • 5.3.3.3. Online
        • 5.3.3.4. Tobacconists
      • 5.3.4. Global Smoking Cessation Aids Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Smoking Cessation Aids (Price)
      • 5.4.1. Global Smoking Cessation Aids by: Type (Price)
  • 6. Smoking Cessation Aids: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Reckitt Benckiser (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Roche (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Novartis (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Johnson and Johnson (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bayer (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cipla (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Takeda Pharmaceuticals (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. NJOY (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Smoking Cessation Aids Sale, by Type, Application, Distribution Channels and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Smoking Cessation Aids (Value)
      • 7.2.1. Global Smoking Cessation Aids by: Type (Value)
        • 7.2.1.1. Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays)
        • 7.2.1.2. Spray
        • 7.2.1.3. Drug
        • 7.2.1.4. Electronic Cigarettes
        • 7.2.1.5. Others
      • 7.2.2. Global Smoking Cessation Aids by: Application (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Online Pharmacies
      • 7.2.3. Global Smoking Cessation Aids by: Distribution Channels (Value)
        • 7.2.3.1. Supermarkets
        • 7.2.3.2. Vape Shops
        • 7.2.3.3. Online
        • 7.2.3.4. Tobacconists
      • 7.2.4. Global Smoking Cessation Aids Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Smoking Cessation Aids (Volume)
      • 7.3.1. Global Smoking Cessation Aids by: Type (Volume)
        • 7.3.1.1. Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays)
        • 7.3.1.2. Spray
        • 7.3.1.3. Drug
        • 7.3.1.4. Electronic Cigarettes
        • 7.3.1.5. Others
      • 7.3.2. Global Smoking Cessation Aids by: Application (Volume)
        • 7.3.2.1. Hospital Pharmacies
        • 7.3.2.2. Retail Pharmacies
        • 7.3.2.3. Online Pharmacies
      • 7.3.3. Global Smoking Cessation Aids by: Distribution Channels (Volume)
        • 7.3.3.1. Supermarkets
        • 7.3.3.2. Vape Shops
        • 7.3.3.3. Online
        • 7.3.3.4. Tobacconists
      • 7.3.4. Global Smoking Cessation Aids Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Smoking Cessation Aids (Price)
      • 7.4.1. Global Smoking Cessation Aids by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Smoking Cessation Aids: by Type(USD Million)
  • Table 2. Smoking Cessation Aids Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays) , by Region USD Million (2016-2021)
  • Table 3. Smoking Cessation Aids Spray , by Region USD Million (2016-2021)
  • Table 4. Smoking Cessation Aids Drug , by Region USD Million (2016-2021)
  • Table 5. Smoking Cessation Aids Electronic Cigarettes , by Region USD Million (2016-2021)
  • Table 6. Smoking Cessation Aids Others , by Region USD Million (2016-2021)
  • Table 7. Smoking Cessation Aids: by Application(USD Million)
  • Table 8. Smoking Cessation Aids Hospital Pharmacies , by Region USD Million (2016-2021)
  • Table 9. Smoking Cessation Aids Retail Pharmacies , by Region USD Million (2016-2021)
  • Table 10. Smoking Cessation Aids Online Pharmacies , by Region USD Million (2016-2021)
  • Table 11. Smoking Cessation Aids: by Distribution Channels(USD Million)
  • Table 12. Smoking Cessation Aids Supermarkets , by Region USD Million (2016-2021)
  • Table 13. Smoking Cessation Aids Vape Shops , by Region USD Million (2016-2021)
  • Table 14. Smoking Cessation Aids Online , by Region USD Million (2016-2021)
  • Table 15. Smoking Cessation Aids Tobacconists , by Region USD Million (2016-2021)
  • Table 16. South America Smoking Cessation Aids, by Country USD Million (2016-2021)
  • Table 17. South America Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 18. South America Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 19. South America Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 20. Brazil Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 21. Brazil Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 22. Brazil Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 23. Argentina Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 24. Argentina Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 25. Argentina Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 26. Rest of South America Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 27. Rest of South America Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 28. Rest of South America Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 29. Asia Pacific Smoking Cessation Aids, by Country USD Million (2016-2021)
  • Table 30. Asia Pacific Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 31. Asia Pacific Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 32. Asia Pacific Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 33. China Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 34. China Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 35. China Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 36. Japan Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 37. Japan Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 38. Japan Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 39. India Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 40. India Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 41. India Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 42. South Korea Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 43. South Korea Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 44. South Korea Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 45. Taiwan Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 46. Taiwan Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 47. Taiwan Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 48. Australia Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 49. Australia Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 50. Australia Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 54. Europe Smoking Cessation Aids, by Country USD Million (2016-2021)
  • Table 55. Europe Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 56. Europe Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 57. Europe Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 58. Germany Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 59. Germany Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 60. Germany Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 61. France Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 62. France Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 63. France Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 64. Italy Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 65. Italy Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 66. Italy Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 67. United Kingdom Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 68. United Kingdom Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 69. United Kingdom Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 70. Netherlands Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 71. Netherlands Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 72. Netherlands Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 73. Rest of Europe Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 74. Rest of Europe Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 75. Rest of Europe Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 76. MEA Smoking Cessation Aids, by Country USD Million (2016-2021)
  • Table 77. MEA Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 78. MEA Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 79. MEA Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 80. Middle East Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 81. Middle East Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 82. Middle East Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 83. Africa Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 84. Africa Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 85. Africa Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 86. North America Smoking Cessation Aids, by Country USD Million (2016-2021)
  • Table 87. North America Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 88. North America Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 89. North America Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 90. United States Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 91. United States Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 92. United States Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 93. Canada Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 94. Canada Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 95. Canada Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 96. Mexico Smoking Cessation Aids, by Type USD Million (2016-2021)
  • Table 97. Mexico Smoking Cessation Aids, by Application USD Million (2016-2021)
  • Table 98. Mexico Smoking Cessation Aids, by Distribution Channels USD Million (2016-2021)
  • Table 99. Smoking Cessation Aids Sales: by Type(unit)
  • Table 100. Smoking Cessation Aids Sales Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays) , by Region unit (2016-2021)
  • Table 101. Smoking Cessation Aids Sales Spray , by Region unit (2016-2021)
  • Table 102. Smoking Cessation Aids Sales Drug , by Region unit (2016-2021)
  • Table 103. Smoking Cessation Aids Sales Electronic Cigarettes , by Region unit (2016-2021)
  • Table 104. Smoking Cessation Aids Sales Others , by Region unit (2016-2021)
  • Table 105. Smoking Cessation Aids Sales: by Application(unit)
  • Table 106. Smoking Cessation Aids Sales Hospital Pharmacies , by Region unit (2016-2021)
  • Table 107. Smoking Cessation Aids Sales Retail Pharmacies , by Region unit (2016-2021)
  • Table 108. Smoking Cessation Aids Sales Online Pharmacies , by Region unit (2016-2021)
  • Table 109. Smoking Cessation Aids Sales: by Distribution Channels(unit)
  • Table 110. Smoking Cessation Aids Sales Supermarkets , by Region unit (2016-2021)
  • Table 111. Smoking Cessation Aids Sales Vape Shops , by Region unit (2016-2021)
  • Table 112. Smoking Cessation Aids Sales Online , by Region unit (2016-2021)
  • Table 113. Smoking Cessation Aids Sales Tobacconists , by Region unit (2016-2021)
  • Table 114. South America Smoking Cessation Aids Sales, by Country unit (2016-2021)
  • Table 115. South America Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 116. South America Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 117. South America Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 118. Brazil Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 119. Brazil Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 120. Brazil Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 121. Argentina Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 122. Argentina Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 123. Argentina Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 124. Rest of South America Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 125. Rest of South America Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 126. Rest of South America Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 127. Asia Pacific Smoking Cessation Aids Sales, by Country unit (2016-2021)
  • Table 128. Asia Pacific Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 129. Asia Pacific Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 130. Asia Pacific Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 131. China Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 132. China Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 133. China Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 134. Japan Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 135. Japan Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 136. Japan Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 137. India Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 138. India Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 139. India Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 140. South Korea Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 141. South Korea Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 142. South Korea Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 143. Taiwan Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 144. Taiwan Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 145. Taiwan Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 146. Australia Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 147. Australia Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 148. Australia Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 149. Rest of Asia-Pacific Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 150. Rest of Asia-Pacific Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 151. Rest of Asia-Pacific Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 152. Europe Smoking Cessation Aids Sales, by Country unit (2016-2021)
  • Table 153. Europe Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 154. Europe Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 155. Europe Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 156. Germany Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 157. Germany Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 158. Germany Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 159. France Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 160. France Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 161. France Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 162. Italy Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 163. Italy Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 164. Italy Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 165. United Kingdom Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 166. United Kingdom Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 167. United Kingdom Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 168. Netherlands Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 169. Netherlands Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 170. Netherlands Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 171. Rest of Europe Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 172. Rest of Europe Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 173. Rest of Europe Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 174. MEA Smoking Cessation Aids Sales, by Country unit (2016-2021)
  • Table 175. MEA Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 176. MEA Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 177. MEA Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 178. Middle East Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 179. Middle East Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 180. Middle East Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 181. Africa Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 182. Africa Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 183. Africa Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 184. North America Smoking Cessation Aids Sales, by Country unit (2016-2021)
  • Table 185. North America Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 186. North America Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 187. North America Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 188. United States Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 189. United States Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 190. United States Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 191. Canada Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 192. Canada Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 193. Canada Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 194. Mexico Smoking Cessation Aids Sales, by Type unit (2016-2021)
  • Table 195. Mexico Smoking Cessation Aids Sales, by Application unit (2016-2021)
  • Table 196. Mexico Smoking Cessation Aids Sales, by Distribution Channels unit (2016-2021)
  • Table 197. Smoking Cessation Aids: by Type(USD/Units)
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Smoking Cessation Aids: by Type(USD Million)
  • Table 209. Smoking Cessation Aids Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays) , by Region USD Million (2022-2027)
  • Table 210. Smoking Cessation Aids Spray , by Region USD Million (2022-2027)
  • Table 211. Smoking Cessation Aids Drug , by Region USD Million (2022-2027)
  • Table 212. Smoking Cessation Aids Electronic Cigarettes , by Region USD Million (2022-2027)
  • Table 213. Smoking Cessation Aids Others , by Region USD Million (2022-2027)
  • Table 214. Smoking Cessation Aids: by Application(USD Million)
  • Table 215. Smoking Cessation Aids Hospital Pharmacies , by Region USD Million (2022-2027)
  • Table 216. Smoking Cessation Aids Retail Pharmacies , by Region USD Million (2022-2027)
  • Table 217. Smoking Cessation Aids Online Pharmacies , by Region USD Million (2022-2027)
  • Table 218. Smoking Cessation Aids: by Distribution Channels(USD Million)
  • Table 219. Smoking Cessation Aids Supermarkets , by Region USD Million (2022-2027)
  • Table 220. Smoking Cessation Aids Vape Shops , by Region USD Million (2022-2027)
  • Table 221. Smoking Cessation Aids Online , by Region USD Million (2022-2027)
  • Table 222. Smoking Cessation Aids Tobacconists , by Region USD Million (2022-2027)
  • Table 223. South America Smoking Cessation Aids, by Country USD Million (2022-2027)
  • Table 224. South America Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 225. South America Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 226. South America Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 227. Brazil Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 228. Brazil Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 229. Brazil Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 230. Argentina Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 231. Argentina Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 232. Argentina Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 233. Rest of South America Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 234. Rest of South America Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 235. Rest of South America Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 236. Asia Pacific Smoking Cessation Aids, by Country USD Million (2022-2027)
  • Table 237. Asia Pacific Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 238. Asia Pacific Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 239. Asia Pacific Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 240. China Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 241. China Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 242. China Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 243. Japan Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 244. Japan Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 245. Japan Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 246. India Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 247. India Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 248. India Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 249. South Korea Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 250. South Korea Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 251. South Korea Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 252. Taiwan Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 253. Taiwan Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 254. Taiwan Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 255. Australia Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 256. Australia Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 257. Australia Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 258. Rest of Asia-Pacific Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 259. Rest of Asia-Pacific Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 260. Rest of Asia-Pacific Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 261. Europe Smoking Cessation Aids, by Country USD Million (2022-2027)
  • Table 262. Europe Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 263. Europe Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 264. Europe Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 265. Germany Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 266. Germany Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 267. Germany Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 268. France Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 269. France Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 270. France Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 271. Italy Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 272. Italy Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 273. Italy Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 274. United Kingdom Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 275. United Kingdom Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 276. United Kingdom Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 277. Netherlands Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 278. Netherlands Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 279. Netherlands Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 280. Rest of Europe Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 281. Rest of Europe Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 282. Rest of Europe Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 283. MEA Smoking Cessation Aids, by Country USD Million (2022-2027)
  • Table 284. MEA Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 285. MEA Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 286. MEA Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 287. Middle East Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 288. Middle East Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 289. Middle East Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 290. Africa Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 291. Africa Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 292. Africa Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 293. North America Smoking Cessation Aids, by Country USD Million (2022-2027)
  • Table 294. North America Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 295. North America Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 296. North America Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 297. United States Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 298. United States Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 299. United States Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 300. Canada Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 301. Canada Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 302. Canada Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 303. Mexico Smoking Cessation Aids, by Type USD Million (2022-2027)
  • Table 304. Mexico Smoking Cessation Aids, by Application USD Million (2022-2027)
  • Table 305. Mexico Smoking Cessation Aids, by Distribution Channels USD Million (2022-2027)
  • Table 306. Smoking Cessation Aids Sales: by Type(unit)
  • Table 307. Smoking Cessation Aids Sales Nicotine Replacement Therapy (NRT Gum, NRT lozenges, NRT Inhalers, NRT Patches and Sprays) , by Region unit (2022-2027)
  • Table 308. Smoking Cessation Aids Sales Spray , by Region unit (2022-2027)
  • Table 309. Smoking Cessation Aids Sales Drug , by Region unit (2022-2027)
  • Table 310. Smoking Cessation Aids Sales Electronic Cigarettes , by Region unit (2022-2027)
  • Table 311. Smoking Cessation Aids Sales Others , by Region unit (2022-2027)
  • Table 312. Smoking Cessation Aids Sales: by Application(unit)
  • Table 313. Smoking Cessation Aids Sales Hospital Pharmacies , by Region unit (2022-2027)
  • Table 314. Smoking Cessation Aids Sales Retail Pharmacies , by Region unit (2022-2027)
  • Table 315. Smoking Cessation Aids Sales Online Pharmacies , by Region unit (2022-2027)
  • Table 316. Smoking Cessation Aids Sales: by Distribution Channels(unit)
  • Table 317. Smoking Cessation Aids Sales Supermarkets , by Region unit (2022-2027)
  • Table 318. Smoking Cessation Aids Sales Vape Shops , by Region unit (2022-2027)
  • Table 319. Smoking Cessation Aids Sales Online , by Region unit (2022-2027)
  • Table 320. Smoking Cessation Aids Sales Tobacconists , by Region unit (2022-2027)
  • Table 321. South America Smoking Cessation Aids Sales, by Country unit (2022-2027)
  • Table 322. South America Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 323. South America Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 324. South America Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 325. Brazil Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 326. Brazil Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 327. Brazil Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 328. Argentina Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 329. Argentina Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 330. Argentina Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 331. Rest of South America Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 332. Rest of South America Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 333. Rest of South America Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 334. Asia Pacific Smoking Cessation Aids Sales, by Country unit (2022-2027)
  • Table 335. Asia Pacific Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 336. Asia Pacific Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 337. Asia Pacific Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 338. China Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 339. China Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 340. China Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 341. Japan Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 342. Japan Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 343. Japan Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 344. India Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 345. India Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 346. India Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 347. South Korea Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 348. South Korea Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 349. South Korea Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 350. Taiwan Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 351. Taiwan Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 352. Taiwan Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 353. Australia Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 354. Australia Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 355. Australia Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 356. Rest of Asia-Pacific Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 357. Rest of Asia-Pacific Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 358. Rest of Asia-Pacific Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 359. Europe Smoking Cessation Aids Sales, by Country unit (2022-2027)
  • Table 360. Europe Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 361. Europe Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 362. Europe Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 363. Germany Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 364. Germany Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 365. Germany Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 366. France Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 367. France Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 368. France Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 369. Italy Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 370. Italy Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 371. Italy Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 372. United Kingdom Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 373. United Kingdom Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 374. United Kingdom Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 375. Netherlands Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 376. Netherlands Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 377. Netherlands Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 378. Rest of Europe Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 379. Rest of Europe Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 380. Rest of Europe Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 381. MEA Smoking Cessation Aids Sales, by Country unit (2022-2027)
  • Table 382. MEA Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 383. MEA Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 384. MEA Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 385. Middle East Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 386. Middle East Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 387. Middle East Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 388. Africa Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 389. Africa Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 390. Africa Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 391. North America Smoking Cessation Aids Sales, by Country unit (2022-2027)
  • Table 392. North America Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 393. North America Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 394. North America Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 395. United States Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 396. United States Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 397. United States Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 398. Canada Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 399. Canada Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 400. Canada Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 401. Mexico Smoking Cessation Aids Sales, by Type unit (2022-2027)
  • Table 402. Mexico Smoking Cessation Aids Sales, by Application unit (2022-2027)
  • Table 403. Mexico Smoking Cessation Aids Sales, by Distribution Channels unit (2022-2027)
  • Table 404. Smoking Cessation Aids: by Type(USD/Units)
  • Table 405. Research Programs/Design for This Report
  • Table 406. Key Data Information from Secondary Sources
  • Table 407. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Smoking Cessation Aids: by Type USD Million (2016-2021)
  • Figure 5. Global Smoking Cessation Aids: by Application USD Million (2016-2021)
  • Figure 6. Global Smoking Cessation Aids: by Distribution Channels USD Million (2016-2021)
  • Figure 7. South America Smoking Cessation Aids Share (%), by Country
  • Figure 8. Asia Pacific Smoking Cessation Aids Share (%), by Country
  • Figure 9. Europe Smoking Cessation Aids Share (%), by Country
  • Figure 10. MEA Smoking Cessation Aids Share (%), by Country
  • Figure 11. North America Smoking Cessation Aids Share (%), by Country
  • Figure 12. Global Smoking Cessation Aids: by Type unit (2016-2021)
  • Figure 13. Global Smoking Cessation Aids: by Application unit (2016-2021)
  • Figure 14. Global Smoking Cessation Aids: by Distribution Channels unit (2016-2021)
  • Figure 15. South America Smoking Cessation Aids Share (%), by Country
  • Figure 16. Asia Pacific Smoking Cessation Aids Share (%), by Country
  • Figure 17. Europe Smoking Cessation Aids Share (%), by Country
  • Figure 18. MEA Smoking Cessation Aids Share (%), by Country
  • Figure 19. North America Smoking Cessation Aids Share (%), by Country
  • Figure 20. Global Smoking Cessation Aids: by Type USD/Units (2016-2021)
  • Figure 21. Global Smoking Cessation Aids share by Players 2021 (%)
  • Figure 22. Global Smoking Cessation Aids share by Players (Top 3) 2021(%)
  • Figure 23. Global Smoking Cessation Aids share by Players (Top 5) 2021(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Reckitt Benckiser (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Reckitt Benckiser (United Kingdom) Revenue: by Geography 2021
  • Figure 27. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 28. Pfizer (United States) Revenue: by Geography 2021
  • Figure 29. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2021
  • Figure 31. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Roche (Switzerland) Revenue: by Geography 2021
  • Figure 33. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Novartis (Switzerland) Revenue: by Geography 2021
  • Figure 35. Johnson and Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 36. Johnson and Johnson (United States) Revenue: by Geography 2021
  • Figure 37. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Bayer (Germany) Revenue: by Geography 2021
  • Figure 39. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 40. Cipla (India) Revenue: by Geography 2021
  • Figure 41. Takeda Pharmaceuticals (Japan) Revenue, Net Income and Gross profit
  • Figure 42. Takeda Pharmaceuticals (Japan) Revenue: by Geography 2021
  • Figure 43. NJOY (United States) Revenue, Net Income and Gross profit
  • Figure 44. NJOY (United States) Revenue: by Geography 2021
  • Figure 45. Global Smoking Cessation Aids: by Type USD Million (2022-2027)
  • Figure 46. Global Smoking Cessation Aids: by Application USD Million (2022-2027)
  • Figure 47. Global Smoking Cessation Aids: by Distribution Channels USD Million (2022-2027)
  • Figure 48. South America Smoking Cessation Aids Share (%), by Country
  • Figure 49. Asia Pacific Smoking Cessation Aids Share (%), by Country
  • Figure 50. Europe Smoking Cessation Aids Share (%), by Country
  • Figure 51. MEA Smoking Cessation Aids Share (%), by Country
  • Figure 52. North America Smoking Cessation Aids Share (%), by Country
  • Figure 53. Global Smoking Cessation Aids: by Type unit (2022-2027)
  • Figure 54. Global Smoking Cessation Aids: by Application unit (2022-2027)
  • Figure 55. Global Smoking Cessation Aids: by Distribution Channels unit (2022-2027)
  • Figure 56. South America Smoking Cessation Aids Share (%), by Country
  • Figure 57. Asia Pacific Smoking Cessation Aids Share (%), by Country
  • Figure 58. Europe Smoking Cessation Aids Share (%), by Country
  • Figure 59. MEA Smoking Cessation Aids Share (%), by Country
  • Figure 60. North America Smoking Cessation Aids Share (%), by Country
  • Figure 61. Global Smoking Cessation Aids: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Reckitt Benckiser (United Kingdom)
  • Pfizer (United States)
  • GlaxoSmithKline (United Kingdom)
  • Roche (Switzerland)
  • Novartis (Switzerland)
  • Johnson and Johnson (United States)
  • Bayer (Germany)
  • Cipla (India)
  • Takeda Pharmaceuticals (Japan)
  • NJOY (United States)
Select User Access Type

Key Highlights of Report


Mar 2022 231 Pages 74 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Smoking Cessation Aids Market Quantitative research analysis
Global Smoking Cessation Aids Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Smoking Cessation Aids market is expected to see a growth of % during projected year 2021 to 2027.
The prominent players of Global Smoking Cessation Aids market are Reckitt Benckiser (United Kingdom), Pfizer (United States), GlaxoSmithKline (United Kingdom), Roche (Switzerland), Novartis (Switzerland), Johnson and Johnson (United States), Bayer (Germany), Cipla (India), Takeda Pharmaceuticals (Japan) and NJOY (United States), to name a few.
In this highly competitive & fast evolving Smoking Cessation Aids industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Smoking Cessation Aids Market Report?

Have a Query? Click Here

Other Related Reports

Sports Shotgun Comprehensive Study by Type (Standard Rifle, Heavy Rifle), Application (Competitive Shooting, Recreation, Others), Sales Channels (Online Sales Channels, Offline Sales Channels), Metal...
$ 3350
Bathroom Vanities Comprehensive Study by Application (Residential, Non-Residential), Installation (Wall Cabinets, Base Cabinets), Distribution Channel (Online, Offline), Size (24 - 35 inch, 38 - 47 i...
$ 3650
Bespoke Units Comprehensive Study by Type (Bespoke Wall Units, Bespoke Floor Units, Bespoke Corner Units, BESPOKE ALCOVE UNITS, Others), Application (High Production Kitchen, Starred Restaurants, Com...
$ 3650
Commercial Sauna Equipment Comprehensive Study by Type (Electric Sauna, Mobile Saunas), Application (Commercial, Residential), Equipment Type (Sauna Accessories, Sauna Components, Sauna Control Units...
$ 3500
Spa Equipment Comprehensive Study by Type (Portable Massage Chairs, Body Care Equipment, Skin Care Equipment, Wax Warmers, Facial Steamers, Other), Application (Beauty Salon, Leisure Place, Other), D...
$ 3650
Banjo Bridge Comprehensive Study by Type (Metal, Wood), Application (Modern Banjo, Classical Banjo), Height (1/2”, 5/8”, 11/16”, Ohters), String (4-String Bridges, 6-String Bridges) Players and Regio...
$ 3500